Drugs / TF 002
last change Sep 2007 re-read 3 minutes ago

TF 002

Developed for
cutaneous mastocytosis
Investigated by
JADO Technologies GmbH

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00457288 Apr → Sep 2007 cutaneous mastocytosis JADO Technologies GmbH Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TF 002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00457288 ↗